4 views left Get unlimited views with a free account

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Mild Cognitive Impairment by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 408 ongoing clinical trials involving Mild Cognitive Impairment
Of the 408 trials,157 trials are in Phase II
Furthermore, 133 trials are in Phase III

Number of ongoing Clinical Trials (for drugs) involving Mild Cognitive Impairment by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Mild Cognitive Impairment, a Central Nervous System disorder. The largest number of ongoing clinical trials for Mild Cognitive Impairment is conducted in North America. Asia-Pacific and Europe are among some of the other prominent regions engaged in Mild Cognitive Impairment-related drug trials.

CuraSen Therapeutics Inc and Johns Hopkins University: The leading ongoing Mild Cognitive Impairment related clinical trial sponsors

CuraSen Therapeutics Inc and Johns Hopkins University are the top sponsors for Mild Cognitive Impairment-related ongoing clinical trials.

Wake Forest University Health Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Eisai Co Ltd and TauRx Therapeutics Ltd are among other notable clinical trial sponsors involved in Mild Cognitive Impairment. A clinical trial sponsor can be a Company, Government, Individual, or Institution.